Acute Coronary Syndrome in Women
Fathima Aaysha Cader1, Nishtha Sareen2, Marcella Calfon Press3
1Cardiology, Kettering General Hospital, UK.
Cardiovascular disease (CVD) affects both sexes, but women often develop it later due to obesity and diabetes. Recognizing sex differences in acute coronary syndrome (ACS) is crucial for improving women
Area of Science:
- Cardiology
- Women's Health
- Sex Differences in Medicine
Background:
- Cardiovascular disease (CVD) remains a leading global cause of mortality despite advances in treatment and diagnosis.
- Women tend to develop CVD later than men, with higher risks associated with obesity and diabetes in older populations.
- Acute coronary syndrome (ACS) presents unique challenges in women, necessitating a focus on sex-specific considerations.
Purpose of the Study:
- To review current knowledge on risk factors, pathophysiology, and management of ACS specifically in women.
- To highlight the importance of recognizing sex-based differences in ACS presentation and treatment.
- To improve understanding and outcomes for women experiencing ACS.
Main Methods:
- Comprehensive literature review of studies focusing on ACS in women.
- Analysis of sex-specific risk factors, including obesity and diabetes.
- Examination of pathophysiological differences and management strategies.
Main Results:
- Identified key risk factors contributing to ACS in women.
- Detailed the pathophysiological mechanisms underlying ACS in this demographic.
- Reviewed current and emerging management approaches tailored for women.
Conclusions:
- Understanding sex differences in ACS is critical for effective clinical practice.
- Tailored management strategies are essential to improve outcomes for women with ACS.
- Further research into sex-specific aspects of CVD is warranted.
More Related Videos
06:39Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
